Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.7405 USD | -0.67% | +10.03% | +117.67% |
May. 24 | Monopar Therapeutics Names Karthik Radhakrishnan as CFO | MT |
May. 24 | Monopar Therapeutics Inc. Announces CFO Changes | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+117.67% | 13.03M | |
+22.08% | 46.93B | |
+37.63% | 39.08B | |
-8.38% | 38.48B | |
+30.26% | 31.01B | |
-13.75% | 26.14B | |
+11.09% | 25.88B | |
+36.18% | 12.53B | |
-6.60% | 11.36B | |
-12.43% | 10.65B |
- Stock Market
- Equities
- MNPR Stock
- News Monopar Therapeutics Inc.
- Roth MKM Adjusts Price Target on Monopar Therapeutics to $3 From $18, Maintains Buy Rating